% | $
Quotes you view appear here for quick access.

AstraZeneca PLC Message Board

  • dinepat203 dinepat203 Jan 31, 2013 1:09 PM Flag

    CEO must buy AMRN -Amarin to score over GSK rival.

    "We will be open to more disruptive acquisitions, larger acquisitions if they make sense," Soriot told reporters.

    But he added: "You have to consider the likelihood of that is lower because I don't think we need a large-scale acquisition to succeed."

    Soriot said any deals he struck would complement increased investment in five existing growth areas - the new heart drug Brilinta, emerging markets, diabetes care, respiratory medicine and Japan.

    Faced with loss of exclusivity on once best-selling medicines and a thin pipeline of new drugs, AstraZeneca needs to consider bold moves to get back on its feet.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
32.86-0.19(-0.57%)Sep 30 4:06 PMEDT